Piper Sandler Appoints Aamer Naseer to Head of Life Sciences Outsourcing and B2B Med Tech
Piper Sandler Appoints Aamer Naseer to Head of Life Sciences Outsourcing and B2B Med Tech
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Key Terms
life sciences outsourcingmedical
Life sciences outsourcing is when biotech, pharmaceutical, and medical device companies hire specialized outside firms to perform tasks such as drug discovery, clinical testing, laboratory analysis, or manufacturing. Like a growing company hiring contractors to build and test a product, it lets firms access expertise and scale work without big upfront investment; investors track it because outsourcing choices affect development speed, costs, regulatory risk, and the timing of potential revenues.
b2b med techmedical
B2B med tech describes companies that make medical devices, diagnostic tools, clinical software or related services and sell them to other organizations—hospitals, clinics, labs, long‑term care facilities or distributors—rather than to individual patients. Investors care because revenue comes from institutional buying cycles, large contracts and reimbursement rules; like selling office equipment to businesses, deals can be big and recurring but sensitive to hospital budgets, regulations and purchasing timelines.
oemstechnical
OEMs, or Original Equipment Manufacturers, are companies that produce the main components or products that other companies use to build finished goods. For investors, OEMs are important because their performance can influence the supply chain, manufacturing costs, and overall market trends in industries like technology, automotive, and electronics. Their success often reflects broader economic health and consumer demand.
MINNEAPOLIS--(BUSINESS WIRE)--
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the appointment of Aamer Naseer to global head of life sciences outsourcing and B2B med tech.
“Aamer has built deep relationships across the life sciences ecosystem and has a strong track record of advising private equity firms, public companies and founders/entrepreneurs. His leadership, sector expertise and commitment to our clients position us exceptionally well to continue expanding our capabilities in this important and evolving space,” said J.P. Peltier, global co-head of investment banking and capital markets.
“I’m honored to step into this new role and excited to work alongside our talented team. This sector continues to evolve and consolidate rapidly and our clients are navigating increasingly dynamic strategic decisions. I’m looking forward to supporting our clients and driving meaningful outcomes across the life sciences outsourcing and the B2B med tech landscape,” said Naseer.
Over the past 25 years, Naseer has worked with a variety of public and private companies including medical manufacturing businesses and outsourcing service providers to med tech OEMs as well as orthopedic, cardiology, dental, aesthetic and ophthalmology companies in the medical device sector.
ABOUT PIPER SANDLER
Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, a tied agent of AHP Capital Management GmbH, authorized and regulated by BaFin; in the Abu Dhabi Global Market through Piper Sandler MENA Ltd., authorized and regulated by the ADGM Financial Services Regulatory Authority; and in Hong Kong through Piper Sandler Hong Kong Ltd., authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.
